Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease-Reference-Cited by-同舟云学术

Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease

Published:2021-02 Issue:2 Volume:44 Page:87-95
ISSN:0210-5705
Container-title:Gastroenterología y Hepatología
language:en
Short-container-title:Gastroenterología y Hepatología

Author:

Penna Francisco Guilherme Cancela,Rosa Rodrigo Macedo,Pereira Fernando H.,Cunha Pedro Ferrari Sales,Sousa Stella Cristina S.,Ferrari Teresa Cristina A.,Cara Carlos,Ferrari Maria de Lourdes A.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference47 articles.

1. Crohn's disease;Torres;Lancet,2017

2. 3rd European Evidence-based Consensus on the diagnosis and management of Crohn's disease 2016: Part 1: Diagnosis and medical management;Gomollon;J Crohn's Colitis,2017

3. Treat to target: a proposed new paradigm for the management of Crohn's disease;Bouguen;Clin Gastroenterol Hepatol,2015

4. Progress with anti-tumor necrosis factor therapeutics for the treatment of inflammatory bowel disease;Fernandes;Immunotherapy,2015

5. Results from the 2nd Scientific Workshop of the ECCO. I: impact of mucosal healing on the course of inflammatory bowel disease;Peyrin-Biroulet;J Crohn's Colitis,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined use of CDAI and blood indices for assessing endoscopic activity in ileocolic Crohn’s disease;BMC Gastroenterology;2023-09-28

2. The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn’s Disease: A Systematic Review and Meta-Analysis;Biomedicines;2023-05-09

3. Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy;World Journal of Gastroenterology;2022-06-21